Starling Oncology, Inc.
STLN- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 119 institutions reported holding it in 13F filings for Q2 2026, worth $217.6M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Starling Oncology, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 38 | 36 | −2 |
| Shares | 13.9M | 15.1M | +1.19M (+8.6%) |
| Value | $7.66M | $21.2M | +$13.5M (+176.5%) |
New holders (9)
Institutions that held Starling Oncology, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 437,579 | $612.6K | 0.00% |
| Tiff Advisory Services Inc | 423,405 | $592.8K | 0.50% |
| Kent Lake Capital LLC | 183,215 | $256.5K | 0.10% |
| XTX Topco Ltd | 46,100 | $64.5K | 0.01% |
| Citadel Advisors LLC | 42,717 | $59.8K | 0.00% |
| Pinebridge Investments, L.P. | 29,779 | $41.7K | 0.00% |
| JustInvest LLC | 21,269 | $29.8K | 0.00% |
| Virtu Financial LLC | 14,044 | $20.0K | 0.00% |
| Prudential Financial Inc | 13,000 | $18.2K | 0.00% |
Sold out (11)
Institutions that held Starling Oncology, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Prosight Management, LP | 455,302 | $250.5K |
| Y-Intercept (Hong Kong) Ltd | 138,899 | $76.4K |
| Old Mission Capital LLC | 52,740 | $29.0K |
| Cubist Systematic Strategies, LLC | 35,621 | $19.6K |
| Jane Street Group, LLC | 22,974 | $12.6K |
| Nwam LLC | 20,000 | $11.0K |
| Point72 Asset Management, L.P. | 14,147 | $7.78K |
| Tower Research Capital LLC (TRC) | 3,640 | $2.00K |
| Point72 Middle East FZE | 3,226 | $1.77K |
| UBS Group AG | 2,414 | $1.33K |
| New York State Common Retirement Fund | 309 | $170 |